Realgar nanoparticlesversusATO arsenic compounds inducein vitroandin vivoactivityagainstmultiple myeloma

MLA

Danka Cholujova, et al. “Realgar NanoparticlesversusATO Arsenic Compounds Inducein Vitroandin Vivoactivityagainstmultiple Myeloma.” British Journal of Haematology, vol. 179, Oct. 2017, pp. 756–71. EBSCOhost, https://doi.org/10.1111/bjh.14974.

APA

Danka Cholujova, Peter Balaz, Erika Dutková, Zdenka Bujnakova, Kenneth C. Anderson, Paul G. Richardson, Teru Hideshima, Richard W.J. Groen, David M. Dorfman, Constantine S. Mitsiades, & Jana Jakubikova. (2017). Realgar nanoparticlesversusATO arsenic compounds inducein vitroandin vivoactivityagainstmultiple myeloma. British Journal of Haematology, 179, 756–771. https://doi.org/10.1111/bjh.14974

Chicago

Danka Cholujova, Peter Balaz, Erika Dutková, Zdenka Bujnakova, Kenneth C. Anderson, Paul G. Richardson, Teru Hideshima, et al. 2017. “Realgar NanoparticlesversusATO Arsenic Compounds Inducein Vitroandin Vivoactivityagainstmultiple Myeloma.” British Journal of Haematology 179 (October): 756–71. doi:10.1111/bjh.14974.